MedTrace Logo

The Effect of Omega-3 Fortified Smoothies on Omega-3 Index and Physical Performance Related Outcomes Among Soldiers

NCT06462898 · Status: RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 100

Last updated 2024-06-18

No results posted yet for this study

Summary

The goal of this clinical trial is to test the effect of omega-3 on physical performance and recovery of Soldiers.

Objectives 1: Assess the impact of 8-weeks of daily consumption of 1600mg of omega-3 fortified smoothie on O3I response.

Objective 2: Determine the relationship between O3I and measures of performance and recovery.

Participants will:

* Be randomly assigned to placebo group or to the omega-3 fortified smoothie group.
* The intervention group will take omega-3 fortified smoothies and controls will consume a non-fortified smoothie, five days a week for 8 weeks.
* Participate in Army Combat Fitness Tests (ACFT)
* Complete surveys that assess dietary intake, physical activity (PAQ) and sleep quality (PSQI).
* Complete a finger prick to determine omega-3 index.

Assessments will be collected pre/post intervention. Researchers will compare intervention and placebo groups to see if omega-3 levels increase, and improve physical performance and recovery.

Conditions

  • Nutrition, Healthy

Interventions

DIETARY_SUPPLEMENT

Omega-3 Fortified Protein Smoothie

Omega-3 powder and protein supplementation.

DIETARY_SUPPLEMENT

Non-Fortified Protein Smoothie

Protein without omega-3 powder supplementation.

Sponsors & Collaborators

  • Henry M. Jackson Foundation for the Advancement of Military Medicine

    collaborator OTHER

  • Uniformed Services University of the Health Sciences

    lead FED

Principal Investigators

  • Melissa Rittenhouse, PhD · Uniformed Services University Health Sciences/Henry M. Jackson Foundation

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
64 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2024-02-01
Primary Completion
2024-09-30
Completion
2024-09-30

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06462898 on ClinicalTrials.gov